Does naltrexone affect craving in abstinent opioid-dependent patients?

Addiction Biology

Volumn 12, Issue 2, 2007, Pages 176-182

  Dijkstra, Boukje A G ^a,b,d   De Jong, Cor A J ^a,b   Bluschke, Sarah M ^b   Krabbe, Paul F M ^c   Van Der Staak, Cees P F ^b  

^a Novadic   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Nijmegen Institute for Scientist Practitioners in Addiction   (Netherlands)

Author keywords

Craving; Craving assessment; Naltrexone; Opioid antagonist; Opioid dependence; Substance use disorder

Indexed keywords

NALTREXONE;

ABSTINENCE; ADULT; ARTICLE; COURSE EVALUATION; DESIRES FOR DRUG QUESTIONNAIRE; DRUG DETOXIFICATION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OBSESSIVE COMPULSIVE DRUG USE SCALE; OPIATE ADDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RELAPSE; URINALYSIS; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; LONGITUDINAL STUDIES; MALE; METHADONE; MIDDLE AGED; MOTIVATION; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; QUESTIONNAIRES; RECURRENCE; SUBSTANCE ABUSE DETECTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34248512522     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2007.00067.x     Document Type: Article

References (41)

1. Anton RF, Moak DH, Latham P, Waid LR, Myrick H, Voronin K, Thevos A, Wang W, Woolson R (2005) Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol 25 : 349 357.
2. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156 : 1758 1764.
3. Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G (1999) A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust 171 : 26 30.
4. Carreno JE, Alvarez CE, Narciso GI, Bascaran MT, Diaz M, Bobes J (2003) Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence. Addict Biol 8 : 429 438.
5. Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B (2000) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35 : 587 593.
6. Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP (2006) Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry 63 : 210 218.
7. Cornish JW, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B, O'Brien CP (1997) Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 14 : 529 534.
8. Davidson D, Palfai T, Bird C, Swift R (1999) Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcohol Clin Exp Res 23 : 195 203.
9. Davidson D, Saha C, Scifres S, Fyffe J, O'Connor S, Selzer C (2004) Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers. Addict Behav 29 : 1253 1258.
10. De Jong CAJ, Laheij RJ, Krabbe PF (2005) General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial. Addiction 100 : 206 215.
11. De Jong CAJ, Schellekens AFA, Ellenbroek B, Franke B, Verkes R-J (2006) The Course of Addiction. Neurobiological Predictors of Chronicity. Den Haag : ZonMw, programma Verslaving.
12. Edenberg HJ, Kranzler HR (2005) The contribution of genetics to addiction therapy approaches. Pharmacol Ther 108 : 86 93.
13. Epstein DH, Preston KL (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) 168 : 31 41.
14. Franken IH, Hendriks VM, van den Brink W (2002) Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav 27 : 675 685.
15. Grusser SM, Thalemann CN, Platz W, Golz J, Partecke G (2006) A new approach to preventing relapse in opiate addicts: a psychometric evaluation. Biol Psychol 71 : 231 235.
16. Johansson BA, Berglund M, Lindgren A (2006) Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review. Addiction 101 : 491 503.
17. Judson BA, Carney TM, Goldstein A (1981) Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison. Drug Alcohol Depend 7 : 325 346.
18. Kirchmayer U, Davoli M, Verster AD, Amato L, Ferri A, Perucci CA (2002) A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction 97 : 1241 1249.
19. Kokkevi A, Hartgers C (1995) EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res 4 : 208 211.
20. Krupitsky EM, Zvartau EE, Masalov DV, Tsoi MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE (2004) Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Subst Abuse Treat 26 : 285 294.
21. Krupitsky EM, Zvartau EE, Masalov DV, Tsoy MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE (2006) Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat 31 : 319 328.
22. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345 : 1734 1739.
23. Lerner A, Sigal M, Bacalu A, Shiff R, Burganski I, Gelkopf M (1992) A naltrexone double blind placebo controlled study in Israel. Isr J Psychiatry Relat Sci 29 : 36 43.
24. McGregor C, Ali R, White JM, Thomas P, Gowing L (2002) A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug Alcohol Depend 68 : 5 14.
25. Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A (2006) Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev (1 CD001333.
26. Mirin SM, Meyer RE, McNamee HB, McDougle M (1976) Psychopathology, craving, and mood during heroin acquisition: an experimental study. Int J Addict 11 : 525 544.
27. Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB (1999) Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23 : 1386 1394.
28. National Research Council (1978) Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. Arch Gen Psychiatry 35 : 335 340.
29. O'Brien CP (2005) Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry 162 : 1423 1431.
30. O'Connor PG, Fiellin DA (2000) Pharmacologic treatment of heroin-dependent patients. Ann Intern Med 133 : 40 54.
31. O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary- adrenocortical axis. Psychopharmacology (Berl) 160 : 19 29.
32. Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ (2004) A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend 74 : 1 13.
33. Roozen HG, De Jong CAJ, Kerkhof AJFM, Geerlings PJ, Schippers GM (2000) EDOCRA: Manual CRA [EDOCRA: Handleiding CRA]. Sint-Oedenrode : Novadic.
34. Roozen HG, de Waart R, van der Windt DA, van den Brink W, de Jong CA, Kerkhof AJ (2006) A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. Eur Neuropsychopharmacol 16 : 311 323.
35. Roozen HG, Kerkhof AJ, van den Brink W (2003) Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity. Eur Addict Res 9 : 53 58.
36. Rubio G, Manzanares J, Lopez-Munoz F, Alamo C, Ponce G, Jimenez-Arriero MA, Palomo T (2002) Naltrexone improves outcome of a controlled drinking program. J Subst Abuse Treat 23 : 361 366.
37. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54 : 1 42.
38. Sideroff SI, Charuvastra VC, Jarvik ME (1978) Craving in heroin addicts maintained on the opiate antagonist naltrexone. Am J Drug Alcohol Abuse 5 : 415 423.
39. Sinclair JD (2001) Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol 36 : 2 10.
40. Streeton C, Whelan G (2001) Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol Alcohol 36 : 544 552.
41. Sullivan MA, Vosburg SK, Comer SD (2006) Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin. Psychopharmacology (Berl) 189 : 37 46.